Literature DB >> 8396284

Transacting activities of the E7 genes of several types of human papillomavirus.

T Ibaraki1, M Satake, N Kurai, M Ichijo, Y Ito.   

Abstract

In accordance with previous reports by others, the E7 gene of human papillomavirus (HPV) 16, considered to be etiologically associated with cervical cancer, transactivated the E2 promoter of adenovirus. This promoter, however, was equally stimulated by the E7 gene of HPV1, a skin type HPV never associated with human malignancy. A variety of promoters were tested to see the effect of the E7 genes of low-risk and high-risk type HPVs. The result indicated that there was no obvious relationship in the levels of transactivation or transrepression by the E7 gene between low-risk and high-risk types. It has been suggested that the binding of the E7 protein to the product of retinoblastoma susceptibility gene (pRb) is the underlying mechanism by which the E7 protein transactivates the E2 promoter. Therefore, the association of the E7 protein and pRb alone did not seem to fully explain the mechanism by which this protein participates in the activation of transcription and induction of human malignancies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396284     DOI: 10.1007/bf01702398

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  53 in total

1.  Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.

Authors:  M Satake; K Furukawa; Y Ito
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.

Authors:  K Münger; C L Yee; W C Phelps; J A Pietenpol; H L Moses; P M Howley
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Mutational analysis of human papillomavirus type 16 E7 functions.

Authors:  S Watanabe; T Kanda; H Sato; A Furuno; K Yoshiike
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression.

Authors:  A Kimura; A Israël; O Le Bail; P Kourilsky
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

6.  Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells.

Authors:  H Sato; A Furuno; K Yoshiike
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

7.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

8.  Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA.

Authors:  S Watanabe; K Yoshiike
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

9.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

10.  The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.

Authors:  M S Barbosa; C Edmonds; C Fisher; J T Schiller; D R Lowy; K H Vousden
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

View more
  5 in total

1.  E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.

Authors:  A Hiraiwa; T Kiyono; S Suzuki; M Ohashi; M Ishibashi
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.

Authors:  Joshua Hatterschide; Alexis C Brantly; Miranda Grace; Karl Munger; Elizabeth A White
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.

Authors:  Joshua Hatterschide; Amelia E Bohidar; Miranda Grace; Tara J Nulton; Hee Won Kim; Brad Windle; Iain M Morgan; Karl Munger; Elizabeth A White
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205

4.  YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia.

Authors:  Joshua Hatterschide; Paola Castagnino; Hee Won Kim; Steven M Sperry; Kathleen T Montone; Devraj Basu; Elizabeth A White
Journal:  Elife       Date:  2022-02-16       Impact factor: 8.713

5.  High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.

Authors:  Elizabeth A White; Karl Münger; Peter M Howley
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.